Myomo names Mary-Katherine McClure chief commercial officer as Micah Mitchell exits
MYO•Myomo named Mary-Katherine “Katie” McClure chief commercial officer effective Oct. 12, 2026; Micah Mitchell will leave after a transition period ending Dec. 23, 2026.
1. Leadership change
McClure joins Myomo from Inspire Medical Systems, where she worked since 2018 as revenue grew from about $50 million to nearly $1 billion. She previously held senior medical device sales roles at Medtronic, Tobii Dynavox and Johnson & Johnson.




